Back To The Future? Old Drugs, New Purposes
This article was originally published in Scrip
Executive Summary
Going back to the future has been a bit of a theme for pharma recently, and not because Oct. 21 2015, was the date that Marty McFly and Doc Brown traveled to in Back to the Future II. Recent developments picked up by the media at large include a new use for insulin (in diabetes), and a "miracle" new cure for Parkinson's disease (Novartis' leukemia drug Tasigna (nilotinib), which was first approved in 2007).